165 related articles for article (PubMed ID: 27505444)
21. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
22. The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?
Lahuerta M; Ue F; Hoffman S; Elul B; Kulkarni SG; Wu Y; Nuwagaba-Biribonwoha H; Remien RH; El Sadr W; Nash D
J Health Care Poor Underserved; 2013 Feb; 24(1):359-83. PubMed ID: 23377739
[TBL] [Abstract][Full Text] [Related]
23. Building Quality Improvement Capacity for HIV Programs in Sub-Saharan Africa: An Innovative, Mixed Method Training Course.
Dougherty G; George A; Johnson C; Rondinelli I; Walker L; Rabkin M
J Assoc Nurses AIDS Care; 2018; 29(5):785-794. PubMed ID: 29803605
[No Abstract] [Full Text] [Related]
24. Control beliefs and health locus of control in Ugandan, German and migrated sub-Saharan African HIV infected individuals.
Milz RU; Husstedt IW; Reichelt D; Evers S
J Psychosom Res; 2016 Apr; 83():22-6. PubMed ID: 27020072
[TBL] [Abstract][Full Text] [Related]
25. Closing the gaps in the HIV care continuum.
Barnabas RV; Celum C
PLoS Med; 2017 Nov; 14(11):e1002443. PubMed ID: 29161265
[TBL] [Abstract][Full Text] [Related]
26. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
[TBL] [Abstract][Full Text] [Related]
27. Tackling virological failure in HIV-infected children living in Africa.
Jenabian MA; Costiniuk CT; Mboumba Bouassa RS; Chapdeleine Mekue Mouafo L; Brogan TV; Bélec L
Expert Rev Anti Infect Ther; 2015; 13(10):1213-23. PubMed ID: 26204960
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral therapy in sub-Saharan Africa: myth or reality?
Kebba A
J Antimicrob Chemother; 2003 Nov; 52(5):747-9. PubMed ID: 14563895
[No Abstract] [Full Text] [Related]
29. The fight against COVID-19 in sub-Saharan Africa-a threat to the continuous management of HIV patients: application of the action areas of the Ottawa charter for health promotion.
Tarkang EE
Pan Afr Med J; 2020; 35(Suppl 2):25. PubMed ID: 33623550
[TBL] [Abstract][Full Text] [Related]
30. Sex Differences in Mortality and Loss Among 21,461 Older Adults on Antiretroviral Therapy in Sub-Saharan Africa.
Agarwal M; Lamb MR; Howard AA; Abrams E; El-Sadr WM; Elul B
J Acquir Immune Defic Syndr; 2016 Oct; 73(2):e33-5. PubMed ID: 27632148
[No Abstract] [Full Text] [Related]
31. Using adapted quality-improvement approaches to strengthen community-based health systems and improve care in high HIV-burden sub-Saharan African countries.
Horwood CM; Youngleson MS; Moses E; Stern AF; Barker PM
AIDS; 2015 Jul; 29 Suppl 2():S155-64. PubMed ID: 26102626
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
33. Factors affecting adherence to short-course ARV prophylaxis for preventing mother-to-child transmission of HIV in sub-Saharan Africa: a review and lessons for future elimination.
Colombini M; Stöckl H; Watts C; Zimmerman C; Agamasu E; Mayhew SH
AIDS Care; 2014; 26(7):914-26. PubMed ID: 24354642
[TBL] [Abstract][Full Text] [Related]
34. Improving Engagement in the HIV Care Cascade: A Systematic Review of Interventions Involving People Living with HIV/AIDS as Peers.
Genberg BL; Shangani S; Sabatino K; Rachlis B; Wachira J; Braitstein P; Operario D
AIDS Behav; 2016 Oct; 20(10):2452-2463. PubMed ID: 26837630
[TBL] [Abstract][Full Text] [Related]
35. ChatGPT has the potential to enhance antiretroviral therapy adherence among adolescents with HIV in sub-Saharan Africa.
Kizito S
Med Educ Online; 2023 Dec; 28(1):2246781. PubMed ID: 37563880
[No Abstract] [Full Text] [Related]
36. Lessons from Africa.
Rabkin M; El-Sadr WM; Mugyenyi P; Ramatlapeng MK; De Cock KM
J Acquir Immune Defic Syndr; 2010 Dec; 55 Suppl 2(Suppl 2):S141-3. PubMed ID: 21406985
[TBL] [Abstract][Full Text] [Related]
37. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
38. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review.
Barth RE; van der Loeff MF; Schuurman R; Hoepelman AI; Wensing AM
Lancet Infect Dis; 2010 Mar; 10(3):155-66. PubMed ID: 20185094
[TBL] [Abstract][Full Text] [Related]
39. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
[TBL] [Abstract][Full Text] [Related]
40. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
Verguet S; Stalcup M; Walsh JA
Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
